申请人:Zeneca Limited
公开号:US05693639A1
公开(公告)日:1997-12-02
Compounds of formula I ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A-B have any of the meanings given in the specification, and their pharmaceutically acceptable salts are useful in the treatment of urinery incontinence. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
式I的化合物 ##STR1## 其中R.sup.1,R.sup.2,R.sup.3,R.sup.4,R.sup.5和A-B具有规范中给出的任何含义,其药学上可接受的盐在治疗尿失禁方面是有用的。还披露了制备式I化合物和中间体的药物组合物和过程。